CTT Pharmaceutical Holdings, Inc. (CTTH)
0.055
0.00 (0.00%)
USD |
OTCM |
Oct 22, 16:00
CTT Pharmaceutical Holdings Net Income (Quarterly) : -0.0152M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.0152M |
| March 31, 2026 | -0.0847M |
| December 31, 2025 | -0.0503M |
| September 30, 2025 | -0.0154M |
| June 30, 2025 | -0.0073M |
| March 31, 2025 | -0.0295M |
| December 31, 2024 | -0.0468M |
| September 30, 2024 | -0.0363M |
| June 30, 2024 | -0.1051M |
| March 31, 2024 | -0.062M |
| December 31, 2023 | -0.0064M |
| September 30, 2023 | -0.0009M |
| June 30, 2023 | -0.0098M |
| March 31, 2023 | -0.0251M |
| December 31, 2022 | -0.0642M |
| September 30, 2022 | 0.0184M |
| June 30, 2022 | -0.001M |
| March 31, 2022 | -0.0051M |
| December 31, 2021 | 0.0099M |
| September 30, 2021 | 0.0739M |
| June 30, 2021 | -0.1088M |
| March 31, 2021 | -0.1081M |
| December 31, 2020 | -0.0928M |
| September 30, 2020 | -0.1825M |
| June 30, 2020 | -0.142M |
| Date | Value |
|---|---|
| March 31, 2020 | -0.1709M |
| December 31, 2019 | -0.1459M |
| September 30, 2019 | -0.1636M |
| June 30, 2019 | -0.0674M |
| March 31, 2019 | -0.2192M |
| December 31, 2018 | -0.1842M |
| September 30, 2018 | -0.3582M |
| June 30, 2018 | -1.091M |
| March 31, 2018 | -0.0943M |
| December 31, 2017 | -1.311M |
| September 30, 2017 | -0.0487M |
| June 30, 2017 | -0.1406M |
| March 31, 2017 | -0.0286M |
| December 31, 2016 | 0.0104M |
| September 30, 2016 | -0.1374M |
| June 30, 2016 | -0.2523M |
| March 31, 2016 | -0.2632M |
| December 31, 2015 | -0.4042M |
| September 30, 2015 | -0.3419M |
| June 30, 2015 | -0.3627M |
| March 31, 2015 | -0.3371M |
| December 31, 2014 | 0.2715M |
| September 30, 2014 | -0.0432M |
| June 30, 2014 | -0.0443M |
| March 31, 2014 | -0.029M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 23.00M |
| Corcept Therapeutics, Inc. | 42.14M |
| Veru, Inc. | -6.988M |
| Johnson & Johnson | 210.00M |
| Eli Lilly & Co. | 7.095B |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 0.0152M |
| EPS Diluted (Quarterly) | -0.0003 |
| Enterprise Value | 3.304M |
| Earnings Yield | -5.27% |
| Normalized Earnings Yield | -4.364 |